Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.24.0.1
Stock-Based Compensation
3 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Our 2014 Omnibus Equity Incentive Plan (the “2014 Plan”) authorizes the issuance of distribution equivalent rights, incentive stock options, non-qualified stock options, performance stock, performance units, restricted ordinary shares, restricted stock units, stock appreciation rights, tandem stock appreciation rights and unrestricted ordinary shares to our directors, officer, employees, consultants and advisors. The Company has reserved up to 300,000 shares of common stock for issuance under the 2014 Plan.
From time to time, the Company grants stock options to directors, officers, and employees. These awards are valued at the grant date by determining the fair value of the instruments. The value of each award is amortized on a straight-line basis over the requisite service period.
The following table summarizes stock option activity for the fiscal year ended September 30, 2023 and the three months ended December 31, 2023:
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual Life
Intrinsic
Value
Outstanding at September 30, 2022 87,500 $ 18.81  0.78 $ 771 
Outstanding at December 31, 2022 87,500 $ 18.81  0.52 $ 1,201 
Exercisable at December 31, 2022 87,500 $ 18.81  0.52 $ 1,201 
Outstanding at September 30, 2023 53,750 $ 21.51  1.54 $ 540 
Outstanding at December 31, 2023 53,750 $ 21.51  1.29 $ 450 
Exercisable at December 31, 2023 53,750 $ 21.51  1.29 $ 450 
The Company recognized compensation expense of approximately $50,000 and $0 during the three months ended December 31, 2023 and 2022, respectively, related to stock option awards and restricted stock awards granted to certain employees and officers based on the grant date fair value of the awards, and the revaluation for existing options whereby the expiration date was extended.
As of December 31, 2023, the Company had no unrecognized compensation expense associated with stock option awards.